Kingdom Capital
Kingdom Capital is a venture capital and private equity firm established in 2016 and based in Chesterfield, Missouri. The firm focuses on investing in early and growth stage, as well as mature and established companies, particularly within the healthcare, medical, technology, media, and real estate sectors. Kingdom Capital emphasizes sectors such as artificial intelligence, data science, therapeutics, medical devices, diagnostics, healthcare IT, and life science tools. The firm also fosters a values-driven investment approach, connecting its investors with philanthropic initiatives through the Kingdom Capital Foundation, thereby creating a comprehensive ecosystem that facilitates the flow of capital to its philanthropic community.
Canopy Biosciences is a biotechnology company based in St. Louis, Missouri, founded in 2016. It specializes in providing research tools and services for genetic engineering and personalized medicine. The company's gene editing technology, known as TUNR, works by targeting translation elongation to insert polyA tracks into specific coding regions of the genome. This process effectively reduces the levels of mRNA transcribed from the gene, leading to a suppression of protein expression. The technology was initially developed by Professors Sergej Djuranovic and Rachel Green at Washington University School of Medicine and Johns Hopkins University, respectively. Canopy Biosciences operates as a subsidiary of Bruker Corporation.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at
support@teaserclub.com. Your feedback is most welcome.